0.5388
Femasys Inc Aktie (FEMY) Neueste Nachrichten
Lake Street initiates Femasys stock coverage with buy rating - Investing.com
FEMY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
FEMY Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
FEMY Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Femasys’s FemBloc Pivotal Trial Update: What Investors Should Watch in Women’s Health - TipRanks
New non-surgical permanent birth control clears key global quality hurdle - Stock Titan
Femasys Announces FemBloc Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access - Bitget
Sentiment Watch: Is Femasys Inc stock undervalued right nowJuly 2025 Setups & Low Risk Investment Opportunities - baoquankhu1.vn
Femasys receives CPT code approval for infertility treatment By Investing.com - Investing.com India
FEMY SEC FilingsFEMASYS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Trend Review: Can Femasys Inc benefit from deglobalization2025 Big Picture & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Femasys receives CPT code approval for infertility treatment - Investing.com UK
AMA procedure code supports new infertility option for over 10M US women - Stock Titan
Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination - Bitget
Femasys (FEMY) CEO awarded 729,000 RSUs vesting through 2027 - Stock Titan
Femasys (NASDAQ: FEMY) CFO receives 342,000 restricted stock units - Stock Titan
Femasys (FEMY) CTO reports common stock and option holdings in Form 3 - Stock Titan
How cyclical is Femasys Inc.’s revenue streamJuly 2025 News Drivers & Technical Pattern Based Buy Signals - mfd.ru
Femasys : Shareholder Update – 2025 in Review - marketscreener.com
Can Femasys Inc. sustain its profitabilityJuly 2025 Weekly Recap & Risk Managed Investment Strategies - mfd.ru
Forecast Cut: What dividend growth rate does Femasys Inc offerMarket Risk Summary & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Femasys stock rises on new distribution partnership in Switzerland By Investing.com - Investing.com Australia
Femasys expands European presence with Swiss distribution deal By Investing.com - Investing.com Nigeria
Femasys Inc. Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products - marketscreener.com
Femasys stock rises on new distribution partnership in Switzerland - Investing.com
Femasys expands European presence with Swiss distribution deal - Investing.com
Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products - The Manila Times
Femasys Inc. Expands European Presence with New Distribution Partnership in Switzerland - Quiver Quantitative
Insider Sell: Is Omega Healthcare Investors Inc subject to activist investor interest2025 Major Catalysts & Smart Investment Allocation Tips - baoquankhu1.vn
Trading Action: Can Femasys Inc sustain its profitabilityTake Profit & Accurate Entry/Exit Alerts - baoquankhu1.vn
Femasys Secures Major Order for FemBloc Launch - MSN
Travel Stocks: What is PCARs revenue forecastEarnings Trend Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Returns Recap: Does Ares Management Corporation meet Warren Buffetts criteria2025 Earnings Impact & Growth Oriented Trading Recommendations - baoquankhu1.vn
Femasys Receives Nasdaq Extension to Regain Listing Compliance - The Globe and Mail
Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule - Investing.com
Femasys Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Stock Recap: Will FUFU benefit from geopolitical trendsCPI Data & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Sahm
Femasys receives 180-day Nasdaq extension to meet minimum bid price - Investing.com Nigeria
Femasys secures Nasdaq extension to regain bid price compliance - MSN
Femasys Granted 180-Day Extension By Nasdaq To Regain Compliance With Minimum Bid Price Requirement - TradingView
Nasdaq gives Femasys more time to fix sub-$1 share price by July 2026 - Stock Titan
Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment - Investing.com Nigeria
Dow Update: Why Femasys Inc stock attracts global investorsTrade Volume Summary & AI Forecast Swing Trade Picks - Bộ Nội Vụ
Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment By Investing.com - Investing.com South Africa
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):